Anders D Hove Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Anders D Hove.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Anders D Hove. Anders D Hove is a Director in ARCA biopharma, Inc. ($ABIO) and a Director in Trubion Pharmaceuticals, Inc ($TRBN) and a Director in Anacor Pharmaceuticals, Inc. ($ANAC) and a Director in Edge Therapeutics, Inc. ($EDGE).
Address: C/O VENROCK ASSOCIATES 30 ROCKEFELLER PLAZA, ROOM 5508 NEW YORK 10112 NY
Companies in which Anders D Hove is an Insider
Anacor Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Anders D Hove: Director
Holdings: 0 shares
Latest Transaction: Jun 24 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ARCA biopharma, Inc.
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of Anders D Hove: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 13 2021
$ABIO Market Capitalization: $23.40M
$ABIO Previous Close: $2.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PDS Biotechnology Corp
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Anders D Hove: Director
Holdings: 2,068,582 shares
Current Value: $19,754,958
Latest Transaction: Oct 08 2015
$EDGE Market Capitalization: $272.98M
$EDGE Previous Close: $9.55
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Trubion Pharmaceuticals, Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Anders D Hove: Director
Holdings: 37,154 shares
Latest Transaction: May 28 2009
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Anders D Hove
Sentiment: All, ANAC, ABIO, EDGE, TRBN
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 13 2021 | ABIO | ARCA biopharma, In ... | Hove Anders D | Director | Option Exercise | A | 4.31 | 12,000 | 51,720 | 12,000 | |
| Mar 05 2018 | ABIO | ARCA biopharma, In ... | Hove Anders D | Director | Option Exercise | A | 0.72 | 8,000 | 5,760 | 8,000 | |
| Feb 21 2017 | ABIO | ARCA biopharma, In ... | Hove Anders D | Director | Option Exercise | A | 2.50 | 10,000 | 25,000 | 10,000 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Option Exercise | D | 69.40 | 4,096 | 284,262 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Option Exercise | D | 14.22 | 15,000 | 213,300 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Option Exercise | D | 5.11 | 15,000 | 76,650 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Option Exercise | D | 5.20 | 12,500 | 65,000 | 0 |